Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PTLA

Portola Pharmaceuticals (PTLA) Stock Price, News & Analysis

Portola Pharmaceuticals logo

About Portola Pharmaceuticals Stock (NASDAQ:PTLA)

Advanced Chart

Key Stats

Today's Range
$18.03
$18.03
50-Day Range
$18.03
$18.03
52-Week Range
$5.31
$31.73
Volume
N/A
Average Volume
3.17 million shs
Market Capitalization
$1.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTLA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Portola Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PTLA Stock News Headlines

Portola Middle
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
Fault lines in Portola Valley
Portola-Butler Continuation High School
Eagle Pharmaceuticals
See More Headlines

PTLA Stock Analysis - Frequently Asked Questions

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) released its quarterly earnings data on Monday, May, 11th. The biopharmaceutical company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.74) by $0.14. The company's revenue for the quarter was up 18.9% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Portola Pharmaceuticals investors own include Lexicon Pharmaceuticals (LXRX), Novavax (NVAX), Iovance Biotherapeutics (IOVA), Amarin (AMRN), Editas Medicine (EDIT), Exelixis (EXEL) and Geron (GERN).

Company Calendar

Last Earnings
5/11/2020
Today
8/08/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PTLA
CIK
1269021
Fax
N/A
Employees
324
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$290.66 million
Net Margins
-232.73%
Pretax Margin
N/A
Return on Equity
-267.86%
Return on Assets
-54.66%

Debt

Debt-to-Equity Ratio
4.77
Current Ratio
4.87
Quick Ratio
4.82

Sales & Book Value

Annual Sales
$116.64 million
Price / Sales
12.13
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.67 per share
Price / Book
10.80

Miscellaneous

Outstanding Shares
78,484,000
Free Float
N/A
Market Cap
$1.42 billion
Optionable
Optionable
Beta
2.32
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:PTLA) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners